Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

57-60


Authors Details

Sunil Kumar, Shreya Chaurasia*, Sheezan Imam


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1030

PDF Downloaded: 714


Topical 1% voriconazole ophthalmic solution in the treatment of mycotic corneal ulcer


Original Article

Author Details : Sunil Kumar, Shreya Chaurasia*, Sheezan Imam

Volume : 6, Issue : 1, Year : 2020

Article Page : 57-60

https://doi.org/10.18231/j.ijceo.2020.012



Suggest article by email

Get Permission

Abstract

Fungal keratitis is a major cause of ocular morbidity and unilateral blindness 1worldwide. In India
it contributes to 50% of culture positive cases. 2 Despite the emergence of many new drugs, a cure
remains difficult in many cases. Compared to anti- bacterial, anti-fungal have lower efficacy, lower tissue
penetration and indolent nature of the infection.
This article aims to study effectiveness of topical 1% voriconazole as first line of treatment in 50 patients
of mycotic corneal ulcer.

Keywords: Fungal corneal ulcer, Voriconazole.


How to cite : Kumar S , Chaurasia S, Imam S, Topical 1% voriconazole ophthalmic solution in the treatment of mycotic corneal ulcer. Indian J Clin Exp Ophthalmol 2020;6(1):57-60

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.